Evaxion Biotech A/S (EVAX) Short Interest Ratio & Short Volume $0.92 +0.03 (+3.36%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Evaxion Biotech A/S Short Interest DataEvaxion Biotech A/S (EVAX) has a short interest of 31,400 shares. This marks a -12.78% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.6, indicating that it would take 0.6 days of the average trading volume of 207,612 shares to cover all short positions.Current Short Interest31,400 sharesPrevious Short Interest36,000 sharesChange Vs. Previous Month-12.78%Dollar Volume Sold Short$52,124.00Short Interest Ratio0.6 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares5,866,000 sharesPercentage of Shares Shorted0.54%Today's Trading Volume73,470 sharesAverage Trading Volume207,612 sharesToday's Volume Vs. Average35% Short Selling Evaxion Biotech A/S? Sign up to receive the latest short interest report for Evaxion Biotech A/S and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartEVAX Short Interest Over TimeEVAX Days to Cover Over TimeEVAX Percentage of Float Shorted Over Time Ad WealthPressYour chance to get on the next “60-Second Trade”Ever heard of the “60-Second Trade”? It’s a unique cash flow strategy that lets regular traders target anywhere from $100 to a couple of thousand in extra cash flow in as little as 7 days… In on Monday, out on Friday!Just head over here! Evaxion Biotech A/S Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/202431,400 shares $52,124.00 -12.8%N/A0.6 $1.66 11/15/202436,000 shares $53,280.00 -31.6%N/A0.7 $1.48 10/31/202452,600 shares $137,812.00 -22.0%N/A1.1 $2.62 10/15/202467,400 shares $181,306.00 -21.1%N/A1.4 $2.69 9/30/202485,400 shares $265,594.00 +286.4%N/A1.7 $3.11 9/15/202422,100 shares $66,300.00 -35.2%N/A0.6 $3.00 Get the Latest News and Ratings for EVAX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Evaxion Biotech A/S and its competitors with MarketBeat's FREE daily newsletter. 8/31/202434,100 shares $104,005.00 -24.9%N/A0.8 $3.05 8/15/202445,400 shares $135,746.00 +9.4%N/A1.1 $2.99 7/31/202441,500 shares $118,690.00 -20.4%N/A1.1 $2.86 7/15/202452,100 shares $164,115.00 -40.8%N/A1.4 $3.15 6/30/202488,000 shares $255,200.00 +93.8%N/A2.3 $2.90 6/15/202445,400 shares $140,740.00 +6.3%N/A1 $3.10 5/31/202442,700 shares $156,709.00 -10.9%N/A1.5 $3.67 5/15/202447,900 shares $180,104.00 -10.0%N/A1.4 $3.76 4/30/202453,200 shares $222,908.00 +11.3%N/A1 $4.19 4/15/202447,800 shares $195,980.00 +12.2%N/A0.1 $4.10 3/31/202442,600 shares $136,320.00 -0.9%N/A0.1 $3.20 3/15/202443,000 shares $128,570.00 +56.4%N/A0.1 $2.99 2/29/202427,500 shares $99,000.00 +41.8%N/A0 $3.60 2/15/202419,400 shares $80,510.00 -61.0%N/A0 $4.15 1/31/202449,800 shares $195,714.00 +325.6%N/A0.1 $3.93 1/15/202411,700 shares $93,483.00 -92.5%N/A0.4 $7.99 12/31/2023155,800 shares $106,832.06 -9.1%N/A1.7 $0.69 12/15/2023171,400 shares $113,124.00 -26.9%N/A1.8 $0.66 11/30/2023234,300 shares $187,205.70 +7.8%N/A1.5 $0.80 11/15/2023217,400 shares $161,963.00 -22.8%N/A1.5 $0.75 10/31/2023281,600 shares $315,392.00 -22.5%N/A2.1 $1.12 10/15/2023363,400 shares $308,526.60 -31.6%N/A3.1 $0.85 9/30/2023531,500 shares $442,739.50 +118.9%N/A4.6 $0.83 9/15/2023242,800 shares $182,609.88 +38.5%N/A2.2 $0.75 8/31/2023175,300 shares $145,516.53 -23.8%N/A2.8 $0.83 8/15/2023230,000 shares $233,059.00 -30.7%N/A1.1 $1.01 7/31/2023331,700 shares $411,308.00 -9.9%N/A1.5 $1.24 7/15/2023368,000 shares $463,680.00 -15.6%N/A1.8 $1.26 6/30/2023436,200 shares $567,060.00 -18.4%N/A1.9 $1.30 6/15/2023534,300 shares $694,590.00 +110.1%N/A2.2 $1.30 5/31/2023254,300 shares $386,536.00 -4.0%N/A1.1 $1.52 5/15/2023264,800 shares $415,736.00 +5.5%N/A2.8 $1.57 4/30/2023251,100 shares $316,386.00 -34.3%N/A0.7 $1.26 4/15/2023382,100 shares $596,076.00 -12.1%N/A1 $1.5670%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today! (Ad)Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets.>> You can grab your FREE, laminated copies right here << 3/31/2023434,700 shares $491,211.00 +24.2%N/A1 $1.13 3/15/2023350,100 shares $378,108.00 +31.6%N/A0.6 $1.08 2/28/2023266,100 shares $409,794.00 -20.6%N/A0.4 $1.54 2/15/2023335,200 shares $526,264.00 +74.6%N/A0.6 $1.57 1/31/2023192,000 shares $309,120.00 -11.0%N/A0.3 $1.61 1/15/2023215,800 shares $334,490.00 +572.3%N/A0.7 $1.55 12/30/202232,100 shares $56,977.50 -9.8%N/A0.2 $1.78 12/15/202235,600 shares $71,200.00 +16.0%N/A0.5 $2.00 11/30/202230,700 shares $66,926.00 -26.0%N/A0 $2.18 11/15/202241,500 shares $97,940.00 -39.4%N/A0.1 $2.36 10/31/202268,500 shares $178,100.00 -45.8%N/A0.1 $2.60 10/15/2022126,300 shares $368,796.00 -36.5%N/A0.2 $2.92 9/30/2022198,800 shares $522,844.00 +9.7%N/A0.3 $2.63 9/15/2022181,200 shares $373,272.00 -0.7%N/A0.2 $2.06 8/31/2022182,400 shares $428,640.00 -2.6%N/A5.2 $2.35 8/15/2022187,200 shares $548,496.00 -3.8%N/A4.6 $2.93 7/31/2022194,600 shares $595,476.00 +6.5%N/A0.5 $3.06 7/15/2022182,700 shares $442,134.00 -9.8%N/A0.5 $2.42 6/30/2022202,600 shares $388,992.00 +13.1%N/A0.5 $1.92 6/15/2022179,100 shares $300,888.00 +3.0%N/A0.5 $1.68 5/31/2022173,900 shares $340,844.00 -35.6%N/A0.5 $1.96 5/15/2022270,100 shares $469,974.00 +4,810.9%N/A0.7 $1.74 4/30/20225,500 shares $15,400.00 -41.5%N/A0.2 $2.80 4/15/20229,400 shares $27,072.00 -34.7%N/A0.2 $2.88 3/31/202214,400 shares $43,632.00 +84.6%N/A0.2 $3.03 3/15/20227,800 shares $20,826.00 +116.7%N/A0.1 $2.67 2/28/20223,600 shares $10,944.00 -82.0%N/A0 $3.04 2/15/202220,000 shares $63,800.00 -58.6%N/A0.1 $3.19 1/31/202248,300 shares $151,662.00 -3.0%N/A0.2 $3.14 1/15/202249,800 shares $203,682.00 +28.7%N/A0 $4.09 12/31/202138,700 shares $171,054.00 +25.7%N/A0 $4.42 12/15/202130,800 shares $126,588.00 +37.5%N/A0 $4.11 11/30/202122,400 shares $104,384.00 -57.1%N/A0 $4.66 11/15/202152,200 shares $324,162.00 +78.2%N/A0.1 $6.21 10/29/202129,300 shares $222,973.00 +229.2%N/A0 $7.61 10/15/20218,900 shares $70,488.00 -77.2%N/A0.1 $7.92 9/30/202139,000 shares $375,960.00 -27.9%N/A0.4 $9.64 9/15/202154,100 shares $444,161.00 +57.7%N/A0.6 $8.21 8/31/202134,300 shares $223,979.00 -2.8%N/A0.3 $6.53 8/13/202135,300 shares $205,093.00 No ChangeN/A0.5 $5.81 EVAX Short Interest - Frequently Asked Questions What is Evaxion Biotech A/S's current short interest? Short interest is the volume of Evaxion Biotech A/S shares that have been sold short but have not yet been covered or closed out. As of November 30th, investors have sold 31,400 shares of EVAX short. Learn More on Evaxion Biotech A/S's current short interest. What is a good short interest ratio for Evaxion Biotech A/S? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EVAX shares currently have a short interest ratio of 1.0. Learn More on Evaxion Biotech A/S's short interest ratio. Is Evaxion Biotech A/S's short interest increasing or decreasing? Evaxion Biotech A/S saw a decrease in short interest in November. As of November 30th, there was short interest totaling 31,400 shares, a decrease of 12.8% from the previous total of 36,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Evaxion Biotech A/S's short interest compare to its competitors? Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Evaxion Biotech A/S: Senti Biosciences, Inc. (2.05%), MiNK Therapeutics, Inc. (0.43%), Athira Pharma, Inc. (5.09%), IN8bio, Inc. (1.73%), Cognition Therapeutics, Inc. (7.66%), Cyclo Therapeutics, Inc. (0.67%), PharmaCyte Biotech, Inc. (0.75%), Aptose Biosciences Inc. (0.21%), Turnstone Biologics Corp. (4.02%), BioCardia, Inc. (2.92%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Evaxion Biotech A/S stock? Short selling EVAX is an investing strategy that aims to generate trading profit from Evaxion Biotech A/S as its price is falling. EVAX shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Evaxion Biotech A/S? A short squeeze for Evaxion Biotech A/S occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EVAX, which in turn drives the price of the stock up even further. How often is Evaxion Biotech A/S's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EVAX, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies Senti Biosciences Short Interest Data MiNK Therapeutics Short Interest Data Athira Pharma Short Interest Data IN8bio Short Interest Data Cognition Therapeutics Short Interest Data Cyclo Therapeutics Short Interest Data PharmaCyte Biotech Short Interest Data Aptose Biosciences Short Interest Data Turnstone Biologics Short Interest Data BioCardia Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:EVAX) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evaxion Biotech A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Evaxion Biotech A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
